The Department of Banking News Bulletin 

 Bulletin # 1914
Week Ending October 27, 2000

This bulletin constitutes the only official notification you will receive from this office concerning any of the following applications. Any observations you may have are solicited. Any comments should be in writing to John P. Burke, Banking Commissioner, at the Connecticut Department of Banking, 260 Constitution Plaza, Hartford, CT 06103-1800 or via E-mail to john.burke@ct.gov. Written comments will be considered only if they are received within ten days from the date of this bulletin.

SECURITIES AND BUSINESS INVESTMENTS DIVISION ACTIVITY
Lifeblood Biomedical, Inc. Ordered to Cease and Desist from
Securities Violations; Notice of Intent to Fine Issued

On October 13, 2000, the Banking Commissioner entered an Order to Cease and Desist, Notice of Intent to Fine and Notice of Right to Hearing against Lifeblood Biomedical, Inc. of 101 Southhall Lane, Suite 400, Maitland, Florida. The Order to Cease and Desist and the Notice of Intent to Fine claimed that, from at least March 1997, the corporation sold unregistered, non-exempt promissory notes to the Connecticut public through unregistered agents of issuer in violation of the Connecticut Uniform Securities Act.

The respondent was given an opportunity to request a hearing on the Order to Cease and Desist. A hearing on the Notice of Intent to Fine has been scheduled for December 14, 2000.